Results 11 to 20 of about 19,031 (203)
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells
Cellular Physiology and Biochemistry, 2017 Background: Sulfonylureas, such as glibenclamide, are antidiabetic drugs that stimulate beta-cell insulin secretion by binding to the sulfonylureas receptors (SURs) of adenosine triphosphate-sensitive potassium channels (KATP).
Barbara Salani +8 more
doaj +2 more sources
Clinical Pharmacology: Advances and Applications, 2016 Virendra Rambiritch,1 Poobalan Naidoo,2 Goonaseelan Pillai3 1Pharmacology Department, University of KwaZulu-Natal, Durban, 2Department of Internal Medicine, RK Khan Regional Hospital, Chatsworth, South Africa; 3Scientific Capability Development, Novartis
Rambiritch V, Naidoo P, Pillai G
doaj +1 more source
Interchangeability of glibenclamide-containing drugs
Регуляторные исследования и экспертиза лекарственных средств, 2018 The article analyses the problem of interchangeability of glibenclamide-containing drugs that sometimes lack therapeutic equivalence even though their bioequivalence has been proven.
G. I. Gorodetskaya +8 more
doaj +1 more source
Encapsulation and release characteristics of glibenclamide loaded calcium-alginate beads [PDF]
Química Nova, 2010 The aims of this study were to formulate calcium-alginate beads containing glibenclamide, characterize the resulting microparticles, evaluate the release characteristics of this type of delivery system in an in vitro dissolution test, and compare it with
Dalia Charles-Navarro +8 more
doaj +2 more sources
A Protective Role of Glibenclamide in Inflammation-Associated Injury
Mediators of Inflammation, 2017 Glibenclamide is the most widely used sulfonylurea drug for the treatment of type 2 diabetes mellitus (DM). Recent studies have suggested that glibenclamide reduced adverse neuroinflammation and improved behavioral outcomes following central nervous ...
Gensheng Zhang +5 more
doaj +2 more sources
Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade [PDF]
, 1994 The long-term hypoglycemic activity of sulphonylurea drugs has been attributed, in part at least, to the stimulation of glucose utilization in extra-pancreatic tissues. The novel sulphonylurea, glimepiride, gives rise to a longer lasting reduction in the
Wetekam, Eva-Marlen +5 more
core +1 more source
Iraqi Journal of Pharmaceutical Sciences, 2017 Long-term use of sulfonylureas including chlorpropamide, is known to potentiate the antidiuretic action of arginine vasopressin (AVP), predisposing to hyponatremia.The present study was designed to evaluate the effect of long term use of glibenclamide on
Ali A. Ali
doaj +3 more sources
PLoS ONE, 2015 Activating mutations in the Kir6.2 (KCNJ11) subunit of the ATP-sensitive potassium channel cause neonatal diabetes (ND). Patients with severe mutations also suffer from neurological complications.
Carolina Lahmann +2 more
doaj +1 more source
A KATP channel opener inhibited myocardial reperfusion action potential shortening and arrhythmias [PDF]
, 2001 Low concentrations of certain K<sub>ATP</sub> channel openers have been reported to exert a moderate inhibitory effect on arrhythmias during post-ischaemic early myocardial reperfusion, but the accompanying effects on the time course of ...
Northover, B.J. +5 more
core +1 more source
Регуляторные исследования и экспертиза лекарственных средств, 2020 Rational use of glybenclamide products in the treatment of patients with type 2 diabetes remains a high-priority task. The paper offers a summary of the main groups of glibenclamide drugs and describes pharmacogenetics of glybenclamide.
G. I. Gorodetskaya +3 more
doaj +1 more source